Dentressangle Participations to acquire a majority stake in EDL from Abenex.

Dentressangle Participations, an investment firm, agreed to acquire a majority stake in EDL, a software provider for medical imaging and diagnostic services, from Abenex, an investment company in Paris, France. Financial terms were not disclosed. DENTRESSANGLE Capital and Kylian Lopez, CEO of EDL, will continue this European expansion while strengthening the software’s technological lead by continuously improving the functionalities offered to practitioners and healthcare professionals.